brachydactyly type A7

ORPHA: 933971 Treatment Available

Contents

1. Available Treatments
2. Clinical Presentation
3. Classification & Codes

Available Treatments (1)

Drug	Form	Status	Countries	Lead Time
sclerostin antibody Cold Chain	Subcutaneous injection, 105 mg/1.17 mL	FDA Approved, EMA Approved	7	7d

Clinical Presentation

Signs and symptoms associated with brachydactyly type A7, sourced from HPO and Orphanet clinical annotations.

Hallux valgusSandal gap2-3 toe syndactylyAplasia/Hypoplasia of the middle phalanges of the handShort halluxClinodactyly of the 5th fingerMedially deviated second toeUlnar deviation of the 2nd fingerRadial deviation of the 2nd fingerTriangular epiphysis of the middle phalanx of the 2nd fingerShort 2nd fingerAbsent middle phalanx of 2nd fingerBroad distal phalanx of the thumbFinger symphalangismBroad phalanges of the 2nd toeBroad thumbShort middle phalanx of the 5th toe

Classification & Codes

Orphanet Code

ORPHA:93397

brachydactyly type A7

Orphanet	`ORPHA:93397`
Treatments	1 drug(s)
Symptoms on record	17 signs
Status	published

Treatment Summary

sclerostin antibody

Factual Authority

Last Updated3/20/2026

Clinical DataHPO · Orphanet

Drug DataFDA · EMA · CDSCO